We enable pharmaceutical and biotech companies to launch their medicines commercially by providing full commercialization capabilities based on registration and market authorisation, price and reimbursement.

The physicians, hospitals, clinics and pharmacies who face patients’ unmet needs due to a lack of commercially available therapies in their home countries can count on FarmaMondo to source unlicensed medicines in compliance with all import regulations.

According to the applicable regulations related to the supply of medicines, all requests for access to medicines must come from a healthcare provider. The FarmaMondo group includes Farmacia Centrale, a Swiss international dispensing pharmacy serving patients with valid prescriptions.

We constantly work together with patient advocacy organisations (PAOs) to gain awareness of unmet patient needs. PAOs play a critical role as a trusted resource for their patients, providing timely and accurate information about the process for accessing specialty medicines.